title: Ventral tegmental area leptin receptor neurons specifically project to and regulate cocaine- and amphetamine-regulated transcript neurons of the extended central amygdala.
abstract: Leptin acts via its receptor (LepRb) to regulate neural circuits in concert with body energy stores. In addition to acting on a number of hypothalamic structures, leptin modulates the mesolimbic dopamine (DA) system. To determine the sites at which LepRb neurons might directly influence the mesolimbic DA system, we examined the distribution of LepRb neurons and their projections within mesolimbic brain regions. Although the ventral tegmental area (VTA) contains DA LepRb neurons, LepRb neurons are absent from the amygdala and striatum. Also, LepRb-EGFPf mice (which label projections from LepRb neurons throughout the brain) reveal that few LepRb neurons project to the nucleus accumbens (NAc). In contrast, the central amygdala (CeA) and its rostral extension receive copious projections from LepRb neurons. Indeed, LepRb-specific anterograde tracing demonstrates (and retrograde tracing confirms) that VTA LepRb neurons project to the extended CeA (extCeA) but not the NAc. Consistently, leptin promotes cAMP response element-binding protein phosphorylation in the extCeA, but not NAc, of leptin-deficient animals. Furthermore, transgenic mice expressing the trans-synaptic tracer wheat germ agglutinin in LepRb neurons reveal the innervation of CeA cocaine- and amphetamine-regulated transcript (CART) neurons by LepRb neurons, and leptin suppresses the increased CeA CART expression of leptin-deficient animals. Thus, LepRb VTA neurons represent a subclass of VTA DA neurons that specifically innervates and controls the extCeA; we hypothesize that these neurons primarily modulate CeA-directed behaviors.
authors.affiliation: Division of Metabolism, Endocrinology, and Diabetes, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan 48109, USA.
authors.forename: Rebecca L
authors.initials: RL
authors.lastname: Leshan
authors.forename: Darren M
authors.initials: DM
authors.lastname: Opland
authors.forename: Gwendolyn W
authors.initials: GW
authors.lastname: Louis
authors.forename: Gina M
authors.initials: GM
authors.lastname: Leinninger
authors.forename: Christa M
authors.initials: CM
authors.lastname: Patterson
authors.forename: Christopher J
authors.initials: CJ
authors.lastname: Rhodes
authors.forename: Heike
authors.initials: H
authors.lastname: Münzberg
authors.forename: Martin G
authors.initials: MG
authors.lastname: Myers
mesh_terms: D000661:Amphetamine / Q000032:analysis; D000679:Amygdala / Q000737:chemistry / Q000502:physiology*; D000818:Animals; D003042:Cocaine / Q000032:analysis; D051379:Mice; D008820:Mice, Obese; D008822:Mice, Transgenic; D009434:Neural Pathways / Q000737:chemistry / Q000502:physiology; D009474:Neurons / Q000737:chemistry / Q000145:classification / Q000502:physiology*; D054411:Receptors, Leptin / Q000032:analysis / Q000502:physiology*; D014158:Transcription, Genetic / Q000502:physiology; D017557:Ventral Tegmental Area / Q000737:chemistry / Q000502:physiology*
chemical_list: D054411:Receptors, Leptin; D000661:Amphetamine; D003042:Cocaine
references.citation: J Comp Neurol. 1998 Jun 15;395(4):535-47
references.pmid: 9619505
references.citation: J Comp Neurol. 2005 Dec 5;493(1):72-85
references.pmid: 16255002
references.citation: J Neurosci. 2008 Sep 3;28(36):8908-13
references.pmid: 18768684
references.citation: Cell Metab. 2009 Aug;10(2):89-98
references.pmid: 19656487
references.citation: Neuron. 2006 Jan 19;49(2):191-203
references.pmid: 16423694
references.citation: Nat Neurosci. 2005 Nov;8(11):1445-9
references.pmid: 16251986
references.citation: Obesity (Silver Spring). 2006 Aug;14 Suppl 5:216S-221S
references.pmid: 17021370
references.citation: Brain Res Rev. 2007 Nov;56(1):27-78
references.pmid: 17574681
references.citation: Brain Res. 2007 Jun 4;1152:234-40
references.pmid: 17434149
references.citation: Proc Natl Acad Sci U S A. 2006 Jan 31;103(5):1593-8
references.pmid: 16423896
references.citation: Cell. 2009 Sep 4;138(5):976-89
references.pmid: 19737523
references.citation: J Comp Neurol. 2005 Dec 5;493(1):63-71
references.pmid: 16254991
references.citation: Cell Metab. 2009 Jun;9(6):537-47
references.pmid: 19490908
references.citation: Physiol Behav. 2007 Aug 15;91(5):486-98
references.pmid: 17307205
references.citation: J Neurosci. 2009 Mar 11;29(10):3138-47
references.pmid: 19279251
references.citation: Neuropsychopharmacology. 2009 Apr;34(5):1288-300
references.pmid: 19005467
references.citation: Neuroreport. 1999 Nov 8;10(16):3449-52
references.pmid: 10599860
references.citation: Science. 2000 Jan 7;287(5450):125-8
references.pmid: 10615045
references.citation: Nutr Rev. 2002 Oct;60(10 Pt 2):S1-14; discussion S68-84, 85-7
references.pmid: 12403078
references.citation: J Comp Neurol. 2009 Jun 10;514(5):518-32
references.pmid: 19350671
references.citation: Neuron. 2005 Jan 6;45(1):17-25
references.pmid: 15629699
references.citation: Cell Metab. 2010 Jan;11(1):77-83
references.pmid: 20074530
references.citation: J Androl. 2005 Sep-Oct;26(5):568-77
references.pmid: 16088032
references.citation: J Gerontol A Biol Sci Med Sci. 2001 Aug;56(8):B340-9
references.pmid: 11487592
references.citation: Neuron. 2004 Jun 24;42(6):983-91
references.pmid: 15207242
references.citation: Obesity (Silver Spring). 2006 Aug;14 Suppl 5:208S-212S
references.pmid: 17021368
references.citation: J Clin Invest. 2005 Dec;115(12):3484-93
references.pmid: 16284652
references.citation: Proc Natl Acad Sci U S A. 2002 Nov 12;99(23):15148-53
references.pmid: 12391304
references.citation: J Clin Invest. 2001 Oct;108(8):1113-21
references.pmid: 11602618
references.citation: Neuron. 2006 Sep 21;51(6):811-22
references.pmid: 16982425
references.citation: J Neurosci. 2007 Jun 27;27(26):7021-7
references.pmid: 17596451
references.citation: Brain Res. 2008 Nov 13;1240:119-31
references.pmid: 18823957
references.citation: Cell Metab. 2009 Feb;9(2):117-23
references.pmid: 19187770
references.citation: Am J Physiol Regul Integr Comp Physiol. 2007 Jan;292(1):R47-63
references.pmid: 16959861
references.citation: Nature. 2009 Jun 11;459(7248):837-41
references.pmid: 19448610
references.citation: Neuropsychopharmacology. 2008 Apr;33(5):1127-36
references.pmid: 17637604
references.citation: Psychopharmacology (Berl). 2010 Jan;207(4):535-45
references.pmid: 19823809
references.citation: Nature. 2006 Sep 21;443(7109):289-95
references.pmid: 16988703
references.citation: Endocrinology. 2003 May;144(5):2016-24
references.pmid: 12697710
references.citation: Cancer Res. 2006 Feb 1;66(3):1294-301
references.pmid: 16452182
references.citation: Life Sci. 2003 Jun 27;73(6):759-68
references.pmid: 12801597
references.citation: J Neurosci. 2007 Jan 3;27(1):69-74
references.pmid: 17202473
references.citation: Neuron. 2008 Mar 13;57(5):760-73
references.pmid: 18341995
references.citation: Annu Rev Neurosci. 2007;30:367-98
references.pmid: 17506645
references.citation: Physiol Behav. 2007 Aug 15;91(5):473-8
references.pmid: 17137609
references.citation: Neuron. 2006 Sep 21;51(6):801-10
references.pmid: 16982424